CEO and Company Health24 Oct 2020 14:58
After further consideration of the RNS on Thursday, I feel that DB thought it was good news 2 POC and the improved to 15mins and due to the effect on SP on similar news earlier in the year with the Covid PCR test thought the market would take it as good news.
It is good news, but the market took it as another delay and not the news we are waiting on, BC, sales and approvals.
However, priority for the CEO is the company over shareholders whither we like it or not. The company is in very good health despite lack of sales news (we know there is sales, but prob a small amount). The amount of debit at the beginning of the year has been wiped out other than £1.5million BGF which looks to be next to be on the list. So far £9million transferred into shares, good amount of that sold down to new investors. Ok the fund raise at 80p was a very mixed day, however that raised £8mill, at a guess id say 2 mill of that will be gone. To reiterate at year start 10.5 mill in debit, running out of cashflow. To 1.5mill debit and between 6mill and 8mill in the bank.
Not terrible to be fair
CEO Company health, good, check
New products in that time, check
Moving on hearing and Hep C tests with NHS Manchester and conference in Rwanda check
Future products 2 no POC test, 1 starting testing process, and on the market early 2021.
David Budd has done a good job so far for the company, he is stuck between a rock and a hard place waiting on approvals. We must be close to WHO approval as Phil says, the delay in between is around 2-3 weeks, this is week three on Tuesday.
Lab will be set up with BC now and news expected on that, the RNS on Thursday mentioned POC saliva test using the GDR bead, that shows you how good the validation is going with BC saliva. This was thrown in to say, its going well!
We will be due military sales within the next 37 days end of Autumn, Nov 30th
Reading all the negative comments towards CEO and company while heavily invested and the SP dropping was concerning. I have faith in the CEO and the company. I think those who have sold will regret that move. To all those who hold, onwards and upwards. I only hope that DB does not screw over the wee guys who been patient, supportive financially and on these boards.
Good times are ahead for this BRITISH company and investors.